SS-31peptidereview The search keyword "sr 31 peptide" is a misspelling. The dominant search intent clearly points to the peptide SS-31, also known by its developmental names Elamipretide and Bendavia. This mitochondria-targeting peptide has garnered significant research interest for its potential to improve mitochondrial function, reduce oxidative stress, and mitigate age-related changes. Studies suggest SS-31 can reverse mitochondrial dysfunction and has shown promise in various therapeutic applications.
SS-31 is a synthetic peptide that plays a crucial role in cellular health by specifically targeting mitochondria, the powerhouses of our cells. Its primary mechanism of action involves accumulating within the inner mitochondrial membrane, where it acts as a potent antioxidant. By scavenging reactive oxygen species (ROS) and reducing mitochondrial oxidative stress, SS-31 helps protect mitochondria from damage and dysfunction. This targeted approach is key to its therapeutic potential.Evaluation of the antioxidant peptide SS31 for treatment ...
Research indicates that SS-31 has a compelling amount of promise in slowing or mitigating aging-related changes. Its ability to improve mitochondrial energetics and function has been demonstrated across various studies.Human SR-BI Synthetic Peptide (PEP-0870) For instance, treatment with SS-31 has shown the capacity to rapidly reverse deficits in mitochondrial energetics in aged skeletal muscle, leading to improved muscle function.SS-31 Peptide: A Mitochondrial Targeted Therapeutic ... Beyond aging, SS-31 is being investigated for its benefits in conditions characterized by mitochondrial dysfunction.
The therapeutic applications of SS-31 are broad, reflecting the central role of mitochondria in numerous physiological processes and disease states. Studies have explored its efficacy in:
* Cardiovascular Health: SS-31 has demonstrated beneficial effects on cardiac mitochondrial dysfunction and has been investigated for its role in hypertensive cardiomyopathy.
* Kidney Protection: The peptide is used to target mitochondria and has been found to protect the kidneys from oxidative stress, inflammation, and apoptosis.
* Neurological Conditions: Research suggests SS31 treatment can reduce Aβ production and improve mitochondrial dysfunction, showing potential for conditions like Alzheimer's disease.
* Age-Related Decline: Beyond general aging, SS-31 has shown potential to slow or reverse age-related visual decline and improve skeletal muscle energetics.
* Metabolic Health: SS-31 exerts beneficial effects by reducing oxidative stress and has shown utility in reversing burn-induced insulin resistance.
As a pharmaceutical-grade mitochondria-targeting peptide, SS-31 (Elamipretide) is undergoing extensive clinical trials. While research is ongoing and promising, it's important for individuals to consult with healthcare professionals regarding its use, potential benefits, and side effects. The peptide's unique ability to target and restore mitochondrial health positions it as a significant area of therapeutic developmentA Potential Alzheimer's Treatment - Studies on APP Tg Mice.
In conclusion, SS-31 represents a significant advancement in the field of mitochondrial medicine. Its targeted approach to improving mitochondrial function and reducing oxidative stress holds considerable promise for addressing a range of age-related conditions and diseases.SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.